Sintx Technologies (SINT) Enterprise Value Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.91% |
| Dec 31, 2025 | 12.81% |
| Sep 30, 2025 | -9.36% |
| Jun 30, 2025 | 17.69% |
| Mar 31, 2025 | 15.73% |
| Dec 31, 2024 | 36.83% |
| Sep 30, 2024 | 34.57% |
| Jun 30, 2024 | 40.99% |
| Mar 31, 2024 | 37.38% |
| Dec 31, 2023 | 49.12% |
| Sep 30, 2023 | 38.74% |
| Jun 30, 2023 | 19.86% |
| Mar 31, 2023 | -15.36% |
| Dec 31, 2022 | -51.75% |
| Sep 30, 2022 | -17.77% |
| Jun 30, 2022 | -34.39% |
| Mar 31, 2022 | -37.66% |
| Dec 31, 2021 | -37.86% |
| Sep 30, 2021 | -36.25% |
| Jun 30, 2021 | -35.90% |
| Mar 31, 2021 | -285.72% |
| Dec 31, 2020 | -260.97% |
| Sep 30, 2020 | -112.57% |
| Jun 30, 2020 | -73.67% |
| Mar 31, 2020 | -5.80% |
| Dec 31, 2019 | 36.30% |
| Sep 30, 2019 | 34.92% |
| Jun 30, 2019 | 14.77% |
| Mar 31, 2019 | 19.37% |
| Dec 31, 2018 | 22.02% |
| Sep 30, 2018 | 15.52% |
| Jun 30, 2018 | 10.67% |
| Mar 31, 2018 | 69.82% |
| Dec 31, 2017 | 69.09% |
| Sep 30, 2017 | 35.22% |
| Jun 30, 2017 | 33.09% |
| Mar 31, 2017 | 19.39% |
| Dec 31, 2016 | -44.77% |
| Sep 30, 2016 | -11.96% |
| Jun 30, 2016 | -65.56% |
| Mar 31, 2016 | -54.61% |